Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.

ABSTRACT:

Objective

To estimate the impact of implementing prescription drug monitoring program (PDMP) best practices on prescription opioid use.

Data sources

2007-2012 Medicare claims for noncancer pain patients, and PDMP attributes from the Prescription Drug Abuse Policy System.

Study design

We derived PDMP composite scores using the number of best practices adopted by states (range: 0-14), classifying states as either no PDMP, low strength (0 < score < median), or high strength (score ≥ median). Using generalized linear models, we quantified the association between the PDMP score category and opioid use measures-overall and stratified by disability/age. Sensitivity analyses assessed the general Medicare sample regardless of pain diagnoses, individual PDMP characteristics, an

SUBMITTER: Moyo P 

PROVIDER: S-EPMC6736920 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature